Atlas Trials

Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Clinical trial NCT02500316 · COMPLETED

Trial details

NCT number
NCT02500316
Sponsor
OPKO Health, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Growth Hormone Deficiency (GHD)
Start date
2014-02-01
Primary completion
2023-11-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.